Healthcare & Life Sciences News and Articles

Google News – Biopharma External News

This week in charts: Biotech’s rebound is undeniable - Yahoo Finance

news.google.com · 27 Aug 2026

Google News – Clinical Trials External News

African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials - StreetInsider

news.google.com · 27 Aug 2026

Google News – FDA (biotech/pharma) External News

Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet - Fierce Pharma

news.google.com · 27 Aug 2026

Google News – Oncology External News

Fast-growing California biotech company CG Oncology relocates its HQ to Texas - Currently.com

news.google.com · 27 Aug 2026

Google News – Biotech Funding External News

Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company. - BioPharma Dive

news.google.com · 27 Aug 2026

Google News – FDA (biotech/pharma) External News

Cronus Pharma Launches First FDA-Approved Generic Robenacoxib Injection for Pain Control in Dogs and Cats - BioBuzz

news.google.com · 27 Aug 2026

Google News – FDA (biotech/pharma) External News

Biotech Stocks Facing FDA Decision In September 2026 - rttnews.com

news.google.com · 26 Aug 2026

Google News – Biopharma External News

EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer - Yahoo Finance

news.google.com · 26 Aug 2026

Google News – FDA (biotech/pharma) External News

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - August 26, 2026 - BioSpace

news.google.com · 26 Aug 2026

Google News – FDA (biotech/pharma) External News

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition - finance.yahoo.com

news.google.com · 26 Aug 2026

Google News – FDA (biotech/pharma) External News

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition - Yahoo Finance UK

news.google.com · 26 Aug 2026

Google News – Oncology External News

$7B Biotech Company Leaves OC For Texas, Citing Business Advantages: Report - Patch

news.google.com · 26 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger - Fierce Pharma

news.google.com · 26 Aug 2026

Google News – FDA (biotech/pharma) External News

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - Business Wire

news.google.com · 26 Aug 2026

Google News – Clinical Trials External News

African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials - CEPI

news.google.com · 26 Aug 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

This week in charts: Biotech’s rebound is undeniable - Yahoo Finance

African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials - StreetInsider

Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet - Fierce Pharma

Fast-growing California biotech company CG Oncology relocates its HQ to Texas - Currently.com

Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company. - BioPharma Dive

Cronus Pharma Launches First FDA-Approved Generic Robenacoxib Injection for Pain Control in Dogs and Cats - BioBuzz

Biotech Stocks Facing FDA Decision In September 2026 - rttnews.com

EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer - Yahoo Finance

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - August 26, 2026 - BioSpace

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition - finance.yahoo.com

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition - Yahoo Finance UK

$7B Biotech Company Leaves OC For Texas, Citing Business Advantages: Report - Patch

FDA greenlights Revolution Medicines' pancreatic cancer gamechanger - Fierce Pharma

Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use - Business Wire

African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials - CEPI